Table 1.
Analysis | Comparison | Number of Differentially Expressed Genes | Top Differentially Expressed Genes | Pathway Analysis |
---|---|---|---|---|
Differential expression | Eosinophilic vs. noneosinophilic COPD | 505 | SMPD3 | GO:0050865 regulation of cell activation |
SLC29A1 | GO:0001655 urogenital system development | |||
PIK3R6 | GO:0022407 regulation of cell–cell adhesion | |||
PRSS33 | GO:0044262 cellular carbohydrate metabolic process | |||
CLC | ||||
Eosinophilic COPD vs. eosinophilic controls | 0 | — | — | |
Eosinophilic COPD exacerbators vs. nonexacerbators | 3 | NUDT5 | — | |
ANKRD40 | ||||
BCCIP | ||||
Eosinophil-associated genes | Eosinophilic COPD (n = 49) | 378 | ACSM3 | GO:0030099 myeloid cell differentiation |
IL5RA | GO:0046434 organophosphate catabolic process | |||
ADORA3 | GO:1903706 regulation of hemopoiesis | |||
TEC | ||||
CYSLTR2 | ||||
Noneosinophilic COPD (n = 182) | 114 | SIGELC8 | NA | |
IL5RA | ||||
ADGRE4P | ||||
OLIG2 | ||||
SLC29A1 | ||||
Eosinophilic control subjects (n = 33) | 0 | — |
Definition of abbreviations: ACSM3 = acyl-CoA synthetase medium chain family member 3; ADGRE4P = adhesion G protein-coupled receptor E4, Pseudogene; ADORA3 = adenosine A3 receptor; ANKRD40 = ankyrin repeat domain 40; BCCIP = BRCA2 and CDKN1A interacting protein; CLC = Charcot-Leyden crystal galectin; COPD = chronic obstructive pulmonary disease; COPDGene = genetic epidemiology of COPD; CYSLTR2 = cysteinyl leukotriene receptor 2; GO = gene ontology; IL5RA = IL-5 receptor subunit α; OLIG2 = oligodendrocyte transcription factor 2; NA = not applicable; NUDT5 = nudix hydrolase 5; PIK3R6 = phosphoinositide-3-kinase regulatory subunit 6; PRSS33 = serine protease 33; SIGELC8 = sialic acid-recognizing Ig-like lectin 8; SLC29A1 = solute carrier family 29 member 1 (Augustine Blood Group); SMPD3 = sphingomyelin phosphodiesterase 3; TEC = Tec Protein tyrosine kinase.